ACS and Stable Angina Drugs Flashcards
(30 cards)
1
Q
Nitrates
A
- STABLE ANGINA DRUG
- Release NO and activate guanylyl cyclase, this makes GMP and causes vasodilation
- Significant first pass metabolism (Given by sublingual etc…)
- Risk of developing a tolerance (thiol def., increased superoxide, activation of RAAS…)
- Adverse effects: headaches, ortho hypotension, increased renal Na+ and H2O absorption
- DO NOT COMBINE WITH ED DRUGS
2
Q
Nitroglycerin
A
- STABLE ANGINA DRUG
- type of nitrate
3
Q
Isosorbide dinitrate
A
- STABLE ANGINA DRUG
- type of nitrate
4
Q
Isosorbide mononitrate
A
- STABLE ANGINA DRUG
- type of nitrate
5
Q
Calcium Channel Blockers
A
- STABLE ANGINA DRUG
- prevent myosin light chain function
- 2 types: dihydropyridines and cardioactive CCBs
- Dihydropyridines: work on vascular smooth muscle
- Cardioactive CCBs: work on vascular smooth muscle, cardiac muscle, and cardiac pacemaker cells
6
Q
Amlodipine
A
- STABLE ANGINA DRUG
- dihydropyridine CCB
- long acting
7
Q
Nifedipine
A
- STABLE ANGINA DRUG
- dihydropyridine CCB
- short acting
8
Q
Nicardipine
A
- STABLE ANGINA DRUG
- dihydropyridine CCB
- short acting
9
Q
Diltiazem
A
- STABLE ANGINA DRUG
- Cardioactive CCB
10
Q
Varapamil
A
- STABLE ANGINA DRUG
- Cardioactive CCB
11
Q
β-Blockers
A
- STABLE ANGINA DRUG
- Decrease adrenergic stimulation to heart, and also decrease BP leading to reduced afterload
12
Q
Propranolol
A
- STABLE ANGINA DRUG
- β-Blocker
13
Q
Nadolol
A
- STABLE ANGINA DRUG
- β-Blocker
14
Q
Metoprolol
A
- STABLE ANGINA DRUG
- β-Blocker
15
Q
Atenolol
A
- STABLE ANGINA DRUG
- β-Blocker
16
Q
Ranolazine
A
- STABLE ANGINA DRUG
- Blocks the late Na+ current
- Normalizes the repolarization of cardiac myocytes
- May reduce diastolic tension and compression of coronary vessels in diastole
- Used in stable angina that is refractory to standard meds
17
Q
Antiplatelet drugs
A
- ACS DRUG
- inhibit platelet function
- used to prevent white thrombi in arteries
18
Q
Anticoagulants
A
- ACS DRUG
- regulate functions and synthesis of clotting factors
- prevent red thrombi from forming in veins
19
Q
Thrombolytics
A
- ACS DRUG
- destroy blood clots after they have formed
- re-establish blood flow
20
Q
Aspirin
A
- ACS DRUG (antiplatelet)
- irreversible inhibition of COX to prevent production of TxA2
21
Q
Clopidogrel
A
- ACS DRUG (antiplatelet)
- P2Y12 (ADP) receptor blocker
- inhibits a Gi and therefore increases levels of cAMP, which prevents platelet aggregation
- nonfunctional CYP2C19 allele renders drug inactive (50% chinese, 34%AA, 25% cauc.)
22
Q
Prasugrel
A
- ACS DRUG (antiplatelet)
- P2Y12 (ADP) receptor blocker
- inhibits a Gi and therefore increases levels of cAMP, which prevents platelet aggregation
23
Q
Ticagrelor
A
- ACS DRUG (antiplatelet)
- P2Y12 (ADP) receptor blocker
- inhibits a Gi and therefore increases levels of cAMP, which prevents platelet aggregation
24
Q
Abciximab
A
- ACS DRUG (antiplatelet)
- GP IIB/IIIA inhibitor
- risk of thrombocytopenia
25
Eptifibatide
- ACS DRUG (antiplatelet)
| - GP IIB/IIIA inhibitor
26
Tirofiban
- ACS DRUG (antiplatelet)
| - GP IIB/IIIA inhibitor
27
Alteplase
- ACS DRUG (thrombolytic)
| - Tissue Plasminogen Activator
28
Reteplase
- ACS DRUG (thrombolytic)
| - Tissue Plasminogen Activator
29
Tenecteplase
- ACS DRUG (thrombolytic)
| - Tissue Plasminogen Activator
30
Streptokinase
-ACS DRUG (thrombolytic)